“…In addition the analyzer cannot measure total lymphocyte counts, thus is not usable for monitoring in children where CD4 % are required. However, products under development such as the Daktari TM CD4 Counter (Daktari Diagnostics Inc., Cambridge, MA, USA), the MBio ™ Diagnostics CD4 system (MBio Diagnostics, Boulder, CO, USA), Zyomyx CD4 counter (Zyomyx, Hayward, CA, USA), the CD4 counter developed by the Burnet Institute (Melbourne, Australia) and the CD4 Point-of-Care Technology (BD Biosciences, Franklin Lakes, NJ, USA) may be promising alternatives and will also contribute to a competition on the CD4 point-of-care analyzer market with hopefully the effect of further price reductions to make CD4 cell monitoring widely available (20) .…”